Stock Markets June 18, 2026 01:29 PM

BofA Identifies Leading EDA Stocks as Sector Shows Early Stabilization

Bank of America highlights Cadence and Synopsys as best-positioned electronic design automation firms amid software multiple compression and semiconductor market uncertainty

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
CDNS SNPS

Bank of America singled out Cadence Design Systems and Synopsys as top investment candidates within the electronic design automation (EDA) software space, applying price targets tied to 2027 earnings multiples while noting industry headwinds such as multiple compression, geopolitical risk, and semiconductor demand variability.

BofA Identifies Leading EDA Stocks as Sector Shows Early Stabilization
CDNS SNPS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Bank of America highlights Cadence and Synopsys as leading EDA software investment candidates as sector stabilizes from software multiple compression.
  • Cadence given a $375 price objective tied to a 40x 2027 P/E, with recent collaborations announced with Intel Foundry and Samsung Foundry.
  • Synopsys assigned a $515 price objective based on 29x 2027 P/E; the company posted $2.276 billion in second-quarter revenue and raised its full-year guidance.

Bank of America has outlined its top EDA software stock picks as the sector begins to find firmer footing following recent pressures on software valuations. The firm concentrated on providers of electronic design automation that occupy strategic positions within the global electronics supply chain, while acknowledging that broader software multiple compression continues to weigh on valuations.

In framing its recommendations, Bank of America assessed each company’s competitive positioning, growth outlook, and capacity to withstand a set of industry headwinds. Those headwinds include geopolitical tensions and shifting dynamics across the semiconductor market, both of which can influence customer spending patterns and cross-border sales.


1. Cadence (NASDAQ:CDNS)

For Cadence Design Systems, Bank of America assigned a $375 price objective, a valuation derived by applying 40 times the firm’s estimate for 2027 price-to-earnings. That 40x multiple sits in the lower half of Cadence’s historical trading band of roughly 30x to 54x, according to the bank’s analysis. The firm justifies the valuation on the basis of EDA’s strategic importance amid an increasingly fragmented global electronics supply chain, while also accounting for the recent compression in software sector multiples.

Bank of America flagged a number of downside risks for Cadence. These include potential erosion of market share to competitors; a pullback in semiconductor research and development spending if the macroeconomic environment weakens; escalation of US-China trade tensions that could constrain sales to key customers; accelerated consolidation within the semiconductor industry that may reduce customer spending power; and the risk that Cadence’s moves into adjacent system analysis markets fail to meaningfully lift revenue growth while limiting margin expansion.

The bank also noted recent company developments: Cadence announced an expanded collaboration with Intel Foundry on Intel’s next-generation 14A process technology, and separately reached an agreement with Samsung Foundry to develop intellectual property targeting Samsung’s 2-nanometer process for AI applications. After the Intel announcement, Stifel increased its price target on Cadence’s stock.


2. Synopsys (NASDAQ:SNPS)

Bank of America set a $515 price objective for Synopsys, based on a multiple of 29 times its estimate for 2027 price-to-earnings. That multiple is below the company’s historical median valuation of 36x, and falls within Synopsys’ historical trading range of about 22x to 49x, per the bank’s work. The firm views this valuation as reasonable given growing EDA investment driven by rising chip complexity, while noting near-term concerns tied to intellectual property exposure, the company’s relationship with top customers like Intel, integration of recent acquisitions such as Ansys, and EDA demand in China.

Bank of America identified several downside risks for Synopsys: variability in intellectual property and hardware sales that can affect revenue recognition timing; competitors developing distinctive software capabilities; further geopolitical deterioration that could bring added China-related restrictions; uncertainty around the integration of recent mergers and acquisitions; and exposure to performance issues at major customers like Intel. The bank also observed potential upside scenarios, including market share gains at competitors’ expense, increased government semiconductor investment, accretive acquisitions that expand margins, and faster-than-expected cost improvements boosting operating margins.

Synopsys reported second-quarter revenue of $2.276 billion, which exceeded expectations, and the company subsequently raised its full-year guidance. In response to the quarter, several analysts, including Stifel and Piper Sandler, lifted their price targets while calling out strong growth in Synopsys’ intellectual property business.


This analysis focuses on EDA vendors that are tightly integrated into electronics manufacturing and chip design workflows, recognizing both the structural importance of their software and the near-term valuation pressures facing the broader software sector. Investors should weigh the banks’ stated price objectives and risk factors against ongoing semiconductor market developments and geopolitical developments that could alter customer demand and cross-border sales.

Risks

  • Potential decline in semiconductor R&D spending during an economic downturn could reduce demand for EDA tools, affecting the semiconductor and software sectors.
  • Escalation of US-China trade tensions may limit sales to key customers and lead to added China-related restrictions, impacting global electronics supply chains and EDA vendors.
  • Industry consolidation among semiconductor customers could reduce their spending power, pressuring software vendors’ revenue and margins; merger and integration uncertainty may also affect Synopsys’ near-term performance.

More from Stock Markets

Guggenheim Picks Abivax as Top Biotech Idea Ahead of ABTECT Part Two Readout Jun 18, 2026 Two Approaches to Iran: How Trump’s Memorandum Stacks Up Against Obama’s JCPOA Jun 18, 2026 Options Activity in Moderna Soars to 121,257 Contracts by Early Afternoon Jun 18, 2026 Guyana’s U.N. Candidate Urges Shared Duty to Preserve and Reform the Organization Jun 18, 2026 Chip and Tech Names Lead Thursday’s Market Swings; Select Large- and Small-Caps Post Big Moves Jun 18, 2026